The pathogenesis of Myotonic Dystrophy type 1 (DM1) is linked to unstable CTG repeats in the DMPK gene which induce the mis-splicing to fetal/neonatal isoforms of many transcripts, including those involved in cellular Ca 2+ homeostasis. Here we monitored the splicing of three genes encoding for Ca 2+ transporters and channels (RyR1, SERCA1 and CACN1S) during maturation of primary DM1 muscle cells in parallel with the functionality of the Excitation-Contraction (EC) coupling machinery. At 15 days of differentiation, fetal isoforms of SERCA1 and CACN1S mRNA were significantly higher in DM1 myotubes compared to controls. Parallel functional studies showed that the cytosolic Ca 2+ response to depolarization in DM1 myotubes did not increase during the progression of differentiation, in contrast to control myotubes. While we observed no differences in the size of intracellular Ca 2+ stores, DM1 myotubes showed significantly reduced RyR1 protein levels, uncoupling between the segregated ER/SR Ca 2+ store and the voltage-induced Ca 2+ release machinery, parallel with induction of endoplasmic reticulum (ER) stress markers. In conclusion, our data suggest that perturbed Ca 2+ homeostasis, via activation of ER stress, contributes to muscle degeneration in DM1 muscle cells likely representing a premature senescence phenotype.
Wagner, A.; Steinberg, H. Hans Steinert (1875–1911). J. Neurol. 2008, 255, 1607–1608, doi:10.1007/s00415-008-0004-x.
[3]
Machuca-Tzili, L.; Brook, D.; Hilton-Jones, D. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 2005, 32, 1–18, doi:10.1002/mus.20301.
Cooper, T.A. Chemical reversal of the RNA gain of function in myotonic dystrophy. Proc. Natl. Acad. Sci. USA 2009, 106, 18433–18434, doi:10.1073/pnas.0910643106.
Gomes-Pereira, M.; Monckton, D.G. Chemical modifiers of unstable expanded simple sequence repeats: What goes up, could come down. Mutat. Res. 2006, 598, 15–34, doi:10.1016/j.mrfmmm.2006.01.011.
[8]
Thornell, L.E.; Lindstom, M.; Renault, V.; Klein, A.; Mouly, V.; Ansved, T.; Butler-Browne, G.; Furling, D. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Neuropathol. Appl. Neurobiol. 2009, 35, 603–613, doi:10.1111/j.1365-2990.2009.01014.x.
[9]
Ikezoe, K.; Nakamori, M.; Furuya, H.; Arahata, H.; Kanemoto, S.; Kimura, T.; Imaizumi, K.; Takahashi, M.P.; Sakoda, S.; Fujii, N.; et al. Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle. Acta Neuropathol. 2007, 114, 527–535, doi:10.1007/s00401-007-0267-9.
[10]
Timchenko, N.A.; Cai, Z.J.; Welm, A.L.; Reddy, S.; Ashizawa, T.; Timchenko, L.T. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 2001, 276, 7820–7826.
[11]
Miller, J.W.; Urbinati, C.R.; Teng-Umnuay, P.; Stenberg, M.G.; Byrne, B.J.; Thornton, C.A.; Swanson, M.S. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 2000, 19, 4439–4448, doi:10.1093/emboj/19.17.4439.
[12]
Botta, A.; Vallo, L.; Rinaldi, F.; Bonifazi, E.; Amati, F.; Biancolella, M.; Gambardella, S.; Mancinelli, E.; Angelini, C.; Meola, G.; et al. Gene Expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expr. 2007, 13, 339–351.
[13]
Fanchaouy, M.; Polakova, E.; Jung, C.; Ogrodnik, J.; Shirokova, N.; Niggli, E. Pathways of Abnormal Stress-Induced Ca2+ Influx into Dystrophic Mdx Cardiomyocytes. Cell Calcium 2009, 46, 114–121, doi:10.1016/j.ceca.2009.06.002.
[14]
Szabadkai, G.; Duchen, M.R. Mitochondria: The Hub of cellular Ca2+ signaling. Physiology (Bethesda) 2008, 23, 84–94, doi:10.1152/physiol.00046.2007.
[15]
Bernardi, P. Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79, 1127–1155.
[16]
Cherednichenko, G.; Hurne, A.M.; Fessenden, J.D.; Lee, E.H.; Allen, P.D.; Beam, K.G.; Pessah, I.N. Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc. Natl. Acad. Sci. USA 2004, 101, 15793–15798.
[17]
Kimura, T.; Nakamori, M.; Lueck, J.D.; Pouliquin, P.; Aoike, F.; Fujimura, H.; Dirksen, R.T.; Takahashi, M.P.; Dulhunty, A.F.; Sakoda, S. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 2005, 14, 2189–2200, doi:10.1093/hmg/ddi223.
[18]
Hino, S.; Kondo, S.; Sekiya, H.; Saito, A.; Kanemoto, S.; Murakami, T.; Chihara, K.; Aoki, Y.; Nakamori, M.; Takahashi, M.P.; et al. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet. 2007, 16, 2834–2843, doi:10.1093/hmg/ddm239.
[19]
Tang, Z.Z.; Yarotskyy, V.; Wei, L.; Sobczak, K.; Nakamori, M.; Eichinger, K.; Moxley, R.T.; Dirksen, R.T.; Thornton, C.A. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum. Mol. Genet. 2012, 21, 1312–1324, doi:10.1093/hmg/ddr568.
[20]
Benders, A.A.; Timmermans, J.A.; Oosterhof, A.; Ter Laak, H.J.; van Kuppevelt, T.H.; Wevers, R.A.; Veerkamp, J.H. Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients. Biochem. J. 1993, 293, 269–274.
[21]
Kimura, T.; Takahashi, M.P.; Okuda, Y.; Kaido, M.; Fujimura, H.; Yanagihara, T.; Sakoda, S. The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy. Neurosci. Lett. 2000, 295, 93–96, doi:10.1016/S0304-3940(00)01598-6.
[22]
Kimura, T.; Lueck, J.D.; Harvey, P.J.; Pace, S.M.; Ikemoto, N.; Casarotto, M.G.; Dirksen, R.T.; Dulhunty, A.F. Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling. Cell Calcium 2009, 45, 264–274, doi:10.1016/j.ceca.2008.11.005.
[23]
Futatsugi, A.; Kuwajima, G.; Mikoshiba, K. Tissue-Specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA. Biochem. J. 1995, 305, 373–378.
[24]
Loro, E.; Rinaldi, F.; Malena, A.; Masiero, E.; Novelli, G.; Angelini, C.; Romeo, V.; Sandri, M.; Botta, A.; Vergani, L. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. Cell Death Differ. 2010, 17, 1315–1324, doi:10.1038/cdd.2010.33.
[25]
Botta, A.; Bonifazi, E.; Vallo, L.; Gennarelli, M.; Garre, C.; Salehi, L.; Iraci, R.; Sansone, V.; Meola, G.; Novelli, G. Italian guidelines for molecular analysis in myotonic dystrophies. Acta Myol. 2006, 25, 23–33.
[26]
Botta, A.; Rinaldi, F.; Catalli, C.; Vergani, L.; Bonifazi, E.; Romeo, V.; Loro, E.; Viola, A.; Angelini, C.; Novelli, G. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J. Med. Genet. 2008, 45, 639–646, doi:10.1136/jmg.2008.058909.
[27]
Barreto-Chang, O.L.; Dolmetsch, R.E. Calcium imaging of cortical neurons using Fura-2. AM. J. Vis. Exp. 2009, 23, 1067.
[28]
Brini, M.; de Giorgi, F.; Murgia, M.; Marsault, R.; Massimino, M.L.; Cantini, M.; Rizzuto, R.; Pozzan, T. Subcellular analysis of Ca2+ homeostasis in primary cultures of skeletal muscle myotubes. Mol. Biol. Cell 1997, 8, 129–143.
Weisleder, N.; Brotto, M.; Komazaki, S.; Pan, Z.; Zhao, X.; Nosek, T.; Parness, J.; Takeshima, H.; Ma, J. Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J. Cell Biol. 2006, 174, 639–645, doi:10.1083/jcb.200604166.
[31]
Zhao, Y.; Koebis, M.; Suo, S.; Ohno, S.; Ishiura, S. Regulation of the alternative splicing of sarcoplasmic reticulum Ca(2)(+)-ATPase1 (SERCA1) by Phorbol 12-Myristate 13-Acetate (PMA) via a PKC pathway. Biochem. Biophys. Res. Commun. 2012, 423, 212–217, doi:10.1016/j.bbrc.2012.05.033.
[32]
Maruyama, K.; MacLennan, D.H. Mutation of aspartic Acid-351, Lysine-352, and Lysine-515 alters the Ca2+ transport activity of the Ca2+-ATPase expressed in COS-1 Cells. Proc. Natl. Acad. Sci. USA 1988, 85, 3314–3318, doi:10.1073/pnas.85.10.3314.
[33]
Jacobs, A.E.; Benders, A.A.; Oosterhof, A.; Veerkamp, J.H.; van Mier, P.; Wevers, R.A.; Joosten, E.M. The calcium homeostasis and the membrane potential of cultured muscle cells from patients with myotonic dystrophy. Biochim. Biophys. Acta 1990, 1096, 14–19.
[34]
Damiani, E.; Angelini, C.; Pelosi, M.; Sacchetto, R.; Bortoloso, E.; Margreth, A. skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy. Neuromuscul. Disord. 1996, 6, 33–47, doi:10.1016/0960-8966(95)00016-X.
[35]
Pessah, I.N. Ryanodine receptor acts as a sensor for redox stress. Pest. Manag. Sci. 2001, 57, 941–945, doi:10.1002/ps.391.
[36]
Bravo, R.; Vicencio, J.M.; Parra, V.; Troncoso, R.; Munoz, J.P.; Bui, M.; Quiroga, C.; Rodriguez, A.E.; Verdejo, H.E.; Ferreira, J.; et al. Increased ER-Mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J. Cell Sci. 2011, 124, 2143–2152, doi:10.1242/jcs.080762.
[37]
Chami, M.; Oules, B.; Szabadkai, G.; Tacine, R.; Rizzuto, R.; Paterlini-Brechot, P. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol. Cell 2008, 32, 641–651, doi:10.1016/j.molcel.2008.11.014.
[38]
Tabas, I.; Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13, 184–190, doi:10.1038/ncb0311-184.
[39]
Smith, M.H.; Ploegh, H.L.; Weissman, J.S. Road to ruin: Targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334, 1086–1090, doi:10.1126/science.1209235.
[40]
Rayavarapu, S.; Coley, W.; Nagaraju, K. Endoplasmic reticulum stress in skeletal muscle homeostasis and disease. Curr. Rheumatol. Rep. 2012, 14, 238–243, doi:10.1007/s11926-012-0247-5.
[41]
Ueda, H.; Shimokawa, M.; Yamamoto, M.; Kameda, N.; Mizusawa, H.; Baba, T.; Terada, N.; Fujii, Y.; Ohno, S.; Ishiura, S.; et al. Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy. J. Neurol. Sci. 1999, 162, 38–50, doi:10.1016/S0022-510X(98)00290-1.
[42]
Fugier, C.; Klein, A.F.; Hammer, C.; Vassilopoulos, S.; Ivarsson, Y.; Toussaint, A.; Tosch, V.; Vignaud, A.; Ferry, A.; Messaddeq, N.; et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med. 2011, 17, 720–725, doi:10.1038/nm.2374.
